Answers are grounded in this paper and cite their sources.
Background Laparoscopic sleeve gastrectomy (LSG) represents the most commonly performed bariatric surgery worldwide. Robotic-assisted sleeve gastrectomy (RSG) has emerged as an alternative approach to conventional LSG. However, its higher cost and uncertain clinical advantages have limited widespread adoption. At our center, a hybrid RSG technique was adopted. Objective The purpose of this study is to compare perioperative outcomes, hospitalization cost, 1-year weight reduction, gastroesophageal reflux disease (GERD) status, diabetes mellitus and hypertension outcomes between hybrid RSG and LSG in patients with obesity. Methods We retrospectively analyzed 85 patients with obesity who underwent hybrid RSG or LSG between January 2023 and May 2024. Baseline characteristics, operative variables, postoperative complications, hospitalization cost, weight loss indices, GERD status, and diabetes mellitus and hypertension outcomes were evaluated through 1-year follow-up. Results Of the 85 patients included, 22 underwent hybrid RSG and 63 underwent LSG. No statistically significant differences were detected in the baseline characteristics between the two groups. Hybrid RSG was associated with longer operative time than LSG (158.41 ± 25.93 vs. 125.48 ± 28.56 min, P < 0.001) and higher hospitalization cost (62180.78 ± 7237.77 vs. 46693.87 ± 6054.18 CNY, P < 0.001). No statistically significant between-group differences were detected in intraoperative blood loss, postoperative hospital stays, complications, reoperation, and mortality, or weight loss outcomes at 6 or 12 months. At 12 months, GERD remission, de novo GERD, diabetes and hypertension remission also showed no statistically significant differences. Conclusion In this cohort, hybrid RSG and LSG were both safe and effective for the treatment of obesity. However, hybrid RSG was associated with significantly longer operative time and higher hospitalization cost. No statistically significant between-group differences were detected in 1-year weight loss and obesity-related comorbidity outcomes. Further studies incorporating adjusted analyses, longer follow-up, and comprehensive cost-effectiveness evaluation are needed.
No takes yet. Share an insight, caveat, or question.
Tusuntuoheti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: